Jushi Holdings (JUSHF) Deferred Taxes (2021 - 2022)
Jushi Holdings' (JUSHF) quarterly Deferred Taxes came in at -$18.9 million in Q4 2022, down 320.2% year-on-year from $8.6 million in Q4 2021, and down 71.71% on a QoQ basis from -$11.0 million in Q3 2022.
Jushi Holdings (JUSHF) Deferred Taxes (2021 - 2022) Analysis & Trends
Jushi Holdings (JUSHF) has 2 years of Deferred Taxes data on file, last reported at -$18.9 million in Q4 2022.
- On a quarterly basis, Deferred Taxes fell 320.2% year-over-year to -$18.9 million in Q4 2022; TTM through Dec 2022 was -$40.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$6.1 million, up 21.86% from the prior year.
- Deferred Taxes for Q4 2022 stood at -$18.9 million, down from -$11.0 million in the prior quarter.
- Over the last five years, Deferred Taxes for JUSHF reached as high as -$4.5 million in Q4 2021 and fell as low as -$18.9 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -18.93 Mn |
| Sep 30, 2022 | -11.02 Mn |
| Dec 31, 2021 | -4.50 Mn |
| Sep 30, 2021 | -5.92 Mn |